Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Karyopharm Therapeutics Inc (NASDAQ:KPTI)

8.04
Delayed Data
As of May 04
 -0.59 / -6.84%
Today’s Change
4.83
Today|||52-Week Range
30.82
-39.32%
Year-to-Date

Today’s Trading

Previous close8.63
Today’s open8.63
Day’s range7.97 - 8.67
Volume215,932
Average volume (3 months)300,719
Market cap$342.0M
Dividend yield--
Data as of 4:00pm ET, 05/04/2016

Growth & Valuation

Earnings growth (last year)-36.63%
Earnings growth (this year)+10.15%
Earnings growth (next 5 years)-13.68%
Revenue growth (last year)+9.17%
P/E ratioNM
Price/Sales1,887.83
Price/Book1.72

Competitors

 Today’s
change
Today’s
% change
AKBAAkebia Therapeutics ...-0.19-2.03%
SVASinovac Biotech Ltd+0.01+0.16%
ADMSAdamas Pharmaceutica...-0.42-2.60%
CNCEConcert Pharmaceutic...-0.01-0.07%
Data as of 4:00pm ET, 05/04/2016

Financials

Next reporting dateMay 9, 2016
EPS forecast (this quarter)-$0.72
Annual revenue (last year)$250.0K
Annual profit (last year)-$118.2M
Net profit margin-47,272.40%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michael G. Kauffman
President &
Chief Scientific Officer
Sharon Shacham
Corporate headquarters
Newton, Massachusetts

Forecasts

Partner Offers

Search for Jobs